UCP1 and leprosy: To evaluate the feasibility of a large-scale field serosurvey among contacts of leprosy patients in the Comoros and Madagascar using the anti-PGL-I UCP-LFA, a total of 32,426 tests were conducted between 2019 and 2022 (Fig 3).